FGFR2 Fusion Cholangiocarcinoma Generic Tablet

Pemigatinib is a kind of drug that blocks something called FGFR, which is important in a type of bile duct cancer called cholangiocarcinoma. It’s especially used when there’s a thing called FGFR2 fusion. It works by stopping this FGFR thing from sending signals.

You can get this drug in three doses—4.5 mg, 9 mg, and 13.5 mg. Doctors usually suggest taking a 13.5 mg pill every day for 14 days in a row. But it’s all part of a bigger 21-day plan.

So, each time you get a dose, there are 14 pills in a pack, and they come in bottles. Pemigatinib works on something called the FGFR pathway in cholangiocarcinoma. It’s usually out of whack in this cancer type, and that’s what this drug targets.

It could help stop the cancer from growing or spreading.